HYPERCHOLESTEROLAEMIA
Clinical trials for HYPERCHOLESTEROLAEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERCHOLESTEROLAEMIA trials appear
Sign up with your email to follow new studies for HYPERCHOLESTEROLAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New daily pill aims to prevent heart attacks and strokes in high-risk patients
Disease control OngoingThis large Phase 3 study tests an oral medication called MK-0616 in about 14,550 people at high risk for heart problems due to hardened arteries or high cholesterol. The goal is to see if taking this pill daily can delay or prevent major events like heart attacks, strokes, or eme…
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 17, 2026 11:34 UTC
-
New cholesterol drug leqvio under Long-Term safety watch
Disease control OngoingThis study is checking the long-term safety of a drug called Leqvio in people with very high cholesterol (familial hypercholesterolaemia) or high cholesterol. About 585 patients are being watched for side effects and how well the drug lowers their bad cholesterol. The goal is to …
Matched conditions: HYPERCHOLESTEROLAEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 12, 2026 13:40 UTC